Mexico secured your secure access to medicines and vaccines at low prices, after Cooperation signed by the head of the Instituto Instituto Mexicano del Seguro Social (IMSS) Zoé Robledo with the representative of the Pan American Health Organization (OPS) Cristian Morales this day.
With the agreement, the institute can participate in Regional Revolving Fund for Strategic Public Health Supplies from PAHO, known as Strategic fund for medicines. This is in addition to the 2017 agreement, which IMSS followed Vaccine Revolving Fund of the organization.
“Today we help each other when we create one greater demand which puts us in a better position regionally at a negotiation and of course we were very interested in having all the benefits of joining the fund, ”said Robledo.
In this way, IMSS will have access to an estimated 350 medicines (antiretroviral drugs, cancer and antihypertensive drugs, among others), vaccines and other supplies at more affordable prices.
I know too guarantees quality, safety, efficiency, bioequivalence and bioavailability of medicines, thanks to the World Health Organization’s (WHO) pre-qualification process and the application of recommendations from the FDA and other regulators.
“We go into a pandemic alone, but when we leave we have to do it together, so this unites us, but also gives us a a very safe path for our beneficiaries at their legitimate demand and the demand for drugs of the highest quality, at the highest quality and at the best price that can be obtained, ”added the head of IMSS.
By having options IMSS will be able to optimize its acquisition processes by having alternatives which meets high standards of openness and experience, says PAHO’s representative.
These funds include technical cooperation aspects:
Identify the demand for medicines and vaccines
Strengthen the capacity of national laboratories for quality control
Coordination, through PAHO, with global initiatives such as the World Financial Service for Procurement of Medicines, the Green Light Committee for TB, the Service for Medicines and Diagnostic Tests for HIV-AIDS, the Global Fund to Fight HIV AIDS, Tuberculosis and Malaria, UNITAID and the Antimalarial Drug Service , among others.
With the signing of the agreement IMSS is committed to providing the corresponding budgetary resources, verify that the acquisition of supplies complies with applicable Mexican regulations, as they are completely free to accept or not offer OPS.
PAHO, for its part, will coordinate with the supplier the customs delivery of the products by air or sea, at the destination specified by IMSS, within the period specified in the purchase orders.
Final approval of the IMSS will be subject to the processes of the Federal Commission for Protection With Sanitary Risk (COFEPRIS) at the time of approval of their entry into the country.
MORE ABOUT THIS TOPIC:
Coronavirus in Mexico: reaches 49,698 deaths and 456,100 infections
Mexico and the United Kingdom agreed on international cooperation for access to vaccines and treatments against COVID-19
Oaxaca is the first country in the country to ban the sale of junk food to children